Haematological malignancies
Invited Discussant 995O and 996O
Date
10 Sep 2017Session
Haematological malignanciesPresenters
Tim SomervailleAuthors
T. SomervailleAuthor affiliations
- Leukaemia Biology, Cancer Research UK Manchester Institute, M20 4BX - Manchester/GB
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
5580 - A Multicentre Phase II Trial addressing Lenalidomide (LEN) Maintenance in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) who are not eligible for Autologous Stem Cell Transplantation (ASCT)
Presenter: Marianna Sassone
Session: Haematological malignancies
Resources:
Abstract
887 - Follicular lymphoma: clinical and mollecular characteristics of histologic transformation
Presenter: Miriam Mendez Garcia
Session: Haematological malignancies
Resources:
Abstract
2476 - Prognostic nomogram for overall survival in previously untreated patients with diffuse large B-cell lymphoma
Presenter: Ying Han
Session: Haematological malignancies
Resources:
Abstract
4964 - Does the omission of vincristine affect outcome and survival in patients with diffuse large B-cell lymphoma?
Presenter: Charlott Mörth
Session: Haematological malignancies
Resources:
Abstract
1860 - Preliminary Results of Novel Safety Interventions in Adult Patients (Pts) With Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) in the ZUMA-3 Trial
Presenter: Bijal Shah
Session: Haematological malignancies
Resources:
Abstract
1314 - ZUMA-4 preliminary results: phase 1 study of KTE-C19 chimeric antigen receptor T cell therapy in pediatric and adolescent patients (pts) with relapsed/refractory acute lymphoblastic leukemia (R/R ALL)
Presenter: Daniel Lee
Session: Haematological malignancies
Resources:
Abstract
3834 - Treatment Patterns in Elderly Patients (Pts) with Acute Myeloid Leukemia (AML) in Routine Clinical Care in the United States (US)
Presenter: Jill Bell
Session: Haematological malignancies
Resources:
Abstract
Haematological malignancies: Invited Discussant 997PD, 998PD and 999PD
Presenter: Evangelos Terpos
Session: Haematological malignancies
Resources:
Slides
Webcast
Invited Discussant 1000PD, 1001PD and 1002PD
Presenter: Luis De la Cruz Merino
Session: Haematological malignancies
Resources:
Slides
Webcast
Haematological malignancies: Invited Discussant 1003PD, 1004PD, 1005PD and 1006PD
Presenter: Christian Buske
Session: Haematological malignancies
Resources:
Slides
Webcast